Slingshot members are tracking this event:
FDA delays Nektar Therapeutics' (NKTR) marketing application for NKTR-181 opioid in lower back pain
Do you think this event is important to the companies below? How will it affect their stock price?
|Impact on Stocks
Slingshot Insights Explained
Aug 30, 2019
Don’t see a project related to the catalyst you care about?
Related Keywords Nktr-181, Chronic Lower Back Pain